Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak

CONCLUSION: Tixagevimab/cilgavimab may have protected high-risk populations against infection with the Omicron variant, hospitalization and severe disease during the China COVID-19 pandemic.PMID:37855094 | DOI:10.1080/14787210.2023.2272866

Source: Expert Review of Anti-Infective Therapy - October 19, 2023 Category: Infectious Diseases Authors: Jianhua You Jiaxin Tian Haidi Wu Wenyan Kang Jianru Wen Hongwei Xu Wenbo Shi Zhi Wang Hanyu Wei Yanjun Du Xiang Li Guangyuan Mu Min Zhou Zhidong Gu Jieming Qu Source Type: research